TUCSON, Ariz., April 1, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it will invest $65 million to construct a state-of-the-art facility in Tucson, Arizona that will be a hub for the company’s supply chain, serving as a final-stage manufacturing and sterilization center.
Category Archives: AZBio News
NIH clinical trial evaluating Moderna COVID-19 variant vaccine begins
Early-stage trial to evaluate safety and immunogenicity.
In investigational vaccine designed to protect against the B.1.351 SARS-CoV-2 variant has been administered as part of a new Phase 1 clinical trial evaluating the vaccine candidate’s safety and immunogenicity in adult volunteers. The vaccine, known as mRNA-1273.351, was developed by the biotechnology company ModernaTX, Inc., based in Cambridge, Massachusetts. The trial is led and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The trial will enroll approximately 210 healthy adult volunteers at four clinical research sites in the United States that are part of the NIAID-funded Infectious Diseases Clinical Research Consortium(IDCRC).
BD Announces FDA Emergency Use Authorization for Combination COVID-19, Flu Rapid Antigen Test
FRANKLIN LAKES, N.J., March 30, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) for a new, rapid antigen test that can detect SARS-CoV-2, influenza A and influenza B in a single test.
Mayo Clinic and ASU MedTech Accelerator boosts health startups
The partnership propels a new cohort of next-generation medical technology and service startups forward with one-of-a-kind tools and resources.
Few things have better illustrated the need for innovative medical technologies than the COVID-19 pandemic. The Mayo Clinic and ASU MedTech Accelerator, a flagship program of the Mayo Clinic and ASU Alliance for Health Care, was designed to help empower medical startups to better navigate challenges while bringing forth life-changing health innovations. The second cohort of this program is set to launch March 30, 2021.
Life365 Adds AliveCor’s Personal EKG Technology to their Virtual Care Platform
SCOTTSDALE, AZ, March 30, 2021— Life365, a leading virtual care platform provider, announced its integration of products from AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, to enhance their remote cardiac monitoring solutions for healthcare consumers and patients located outside traditional care settings.
850 PBC Opens on the Phoenix Biomedical Campus
Located adjacent to ASU’s downtown campus, the Phoenix Biomedical Campus (PBC) Innovation Center expands the downtown biomedical corridor to the northern edges of the urban core. Designed to integrate research, entrepreneurial activity, and corporate engagement, the building offers opportunities for meaningful collaboration with the building tenants and community.Continue reading
Equine Amnio Solutions Signs Exclusive Agreement For Distribution Of RenoVō®, A Next-Generation Equine Regenerative Product
ARGYLE, Texas, March 25, 2021 /PRNewswire/ — Equine Amnio Solutions, LLC (EAS), a distributor of advanced, next-generation equine regenerative products, announced today that Covetrus, a global leader in animal-health technology and services, will be the exclusive distributor of the RenoVō® equine allograft throughout the United States.
UArizona Health Sciences, Cancer Center Launching Arizona Clinical Trials Network
Arizona residents, including underserved and underrepresented populations, will have better access to cutting-edge cancer therapies as the UArizona Cancer Center offers its clinical trials at locations across the state.Continue reading
First cases of South African COVID-19 variant detected in Arizona
PHOENIX — The Arizona Department of Health Services (ADHS), Maricopa County Department of Public Health, and Translational Genomics Research Institute (TGen) reported today that the B.1.351 COVID-19 variant strain, commonly referred to as the South African variant, has been confirmed in two test samples from the state.
CND Life Sciences Closes Series Seed Funding Round
Innovators of the Syn-One Test™ Building Market Presence and Infrastructure
PHOENIX, AZ — March 23, 2021 — CND Life Sciences, Inc. (https://cndlifesciences.com/), an innovative medical technology company pioneering the detection, visualization, and quantification of protein deposition in cutaneous nerve fibers, announced today the closing of a $2.4 million series seed financing round. HonorHealth, a local health system serving 1.6 million people in the greater Phoenix area, joined several experienced financial investors in funding the round.